Deltex Medical Group PLC
16 October 2007
16 October 2007
Deltex Medical Group plc
Additional Listing
Deltex Medical Group plc (the 'Company') was notified yesterday that certain of
its current employees have acquired 11,268 ordinary shares of 1p each as the
result of the exercise of an option under the Company's Enterprise Management
Incentive Scheme exercisable over 11,268 shares at a price of 1 pence per
ordinary share.
In addition, the Company' was also notified yesterday that certain of its
current employees have acquired a further 5,000 ordinary shares of 1p each as
the result of the exercise of an option under the Company's Executive Share
Option Scheme exercisable over 5,000 shares at a price of 15 pence per ordinary
share.
Accordingly, application has been made for 16,268 new ordinary shares to be
admitted to trading. The new ordinary shares will rank pari passu with the
existing issued shares of the Company and dealings are expected to commence on
22 October 2007.
Following this, the total number of voting rights in issue will be 92,487,907.
Enquiries:
Deltex Medical Group plc 01243 774 837
Ewan Phillips / Paul Mitchell
Charles Stanley Securities 0207 149 6000
Nominated Adviser
Philip Davies / Carl Holmes
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.